Evidence map›Paper›PMID 22975303›Full record

ArticleFungal genetics and biology : FG & B2012

A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.

Jeongmi Kim, Yong-Joon Cho, Eunsoo Do, Jaehyuk Choi, Guanggan Hu, Brigitte Cadieux, Jongsik Chun, Younghoon Lee, James W Kronstad, Won Hee Jung

Abstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Acidic pH Reduces Fluconazole Susceptibility inJournal of microbiology and biotechnology · 2025
    Article
  4. Infection and immunity · 2025
    Article
  5. Article
  6. The Interkingdom Interaction withJournal of microbiology and biotechnology · 2023
    Article
  7. Combating increased antifungal drug resistance inActa biochimica et biophysica Sinica · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Involvement of Mrs3/4 in Mitochondrial Iron Transport and Metabolism inJournal of microbiology and biotechnology · 2020
    Article
  12. Article
  13. Multicopper Oxidases inJournal of fungi (Basel, Switzerland) · 2020
    Review
  14. Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance inFrontiers in cellular and infection microbiology · 2020
    Article
  15. Candida albicans reprioritizes metal handling during fluconazole stress.Metallomics : integrated biometal science · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Jeongmi KimDepartment of Biotechnology, Chung-Ang University, Anseong 456-756, Republic of Korea.
Yong-Joon Cho
Eunsoo Do
Jaehyuk Choi
Guanggan Hu
Brigitte Cadieux
Jongsik Chun
Younghoon Lee
James W Kronstad
Won Hee Jung
Chung-Ang University · KRCanada's Michael Smith Genome Sciences Centre · CASeoul National University · KRUniversity of British Columbia · CAKorea Advanced Institute of Science and Technology · KR

Funding

Comparative and functional genomics of C. neoformansR01AI053721 · NIAID · UNIVERSITY OF BRITISH COLUMBIA · PI KRONSTAD, JAMES W · 2003 to 2024
$5.4M
NIAID NIH HHS R01 AI053721
6 · The paper itself

Abstract

The high-affinity reductive iron uptake system that includes a ferroxidase (Cfo1) and an iron permease (Cft1) is critical for the pathogenesis of Cryptococcus neoformans. In addition, a mutant lacking CFO1 or CFT1 not only has reduced iron uptake but also displays a markedly increased susceptibility to azole antifungal drugs. Altered antifungal susceptibility of the mutants was of particular interest because the iron uptake system has been proposed as an alternative target for antifungal treatment. In this study, we used transcriptome analysis to begin exploring the molecular mechanisms of altered antifungal susceptibility in a cfo1 mutant. The wild-type strain and the cfo1 mutant were cultured with or without the azole antifungal drug fluconazole and their transcriptomes were compared following sequencing with Illumina Genome Analyzer IIx (GAIIx) technology. As expected, treatment of both strains with fluconazole caused elevated expression of genes in the ergosterol biosynthetic pathway that includes the target enzyme Erg11. Additionally, genes differentially expressed in the cfo1 mutant were involved in iron uptake and homeostasis, mitochondrial functions and respiration. The cfo1 mutant also displayed phenotypes consistent with these changes including a reduced ratio of NAD(+)/NADH and down-regulation of Fe-S cluster synthesis. Moreover, combination treatment of the wild-type strain with fluconazole and the respiration inhibitor diphenyleneiodonium dramatically increased susceptibility to fluconazole. This result supports the hypothesis that down-regulation of genes required for respiration contributed to the altered fluconazole susceptibility of the cfo1 mutant. Overall, our data suggest that iron uptake and homeostasis play a key role in antifungal susceptibility and could be used as novel targets for combination treatment of cryptococcosis. Indeed, we found that iron chelation in combination with fluconazole treatment synergistically inhibited the growth of C. neoformans.

Indexed as

Antifungal AgentsAzolesBiological TransportCeruloplasminCryptococcosisCryptococcus neoformansDrug Resistance, FungalErgosterolFluconazoleFungal ProteinsGene DeletionGene Expression Regulation, FungalHumansIronMicrobial Sensitivity TestsAntifungal AgentsAzolesCeruloplasminErgosterolFluconazoleFungal ProteinsIron

Identifiers

PMID22975303
PMCPMC4706552
OpenAlexW2004193133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.